The main side effects and precautions of Clofazimine/Sempra

Clofazimine (Clofazimine) is one of the anti-leprosy drugs commonly used in clinical practice. Although its antibacterial and immunomodulatory effects have established its important role in leprosy and certain mycobacterial infections, it is still necessary to pay attention to possible side effects and related risk management during long-term use. The most well-known side effect is the change in the color of the skin and mucous membranes. After a period of use, patients may have their skin, conjunctiva, and sweat turn reddish-brown or dark brown. This is due to the deposition of the drug in the skin tissue. Although this phenomenon is not directly life-threatening, it may have an impact on the patient's appearance and psychology. Therefore, doctors usually explain it to the patient in advance before taking the medication to reduce unnecessary worries.

In addition to skin changes, some patients may experience digestive system reactions, such as diarrhea, abdominal pain, or loss of appetite, which are related to the irritating effect of the drug on the gastrointestinal mucosa. If symptoms are mild, they can be tolerated and gradually relieved in most cases, but if symptoms are significant or persist, dose adjustment or adjuvant treatment is required. In rare cases, clofazimine may cause more serious gastrointestinal complications, such as intestinal obstruction, so patients taking the drug long-term need regular monitoring of their gastrointestinal tract. In addition, clofazimine may also have a certain impact on liver function, especially when other antibacterial drugs are combined or used for a long time. Therefore, it is recommended to conduct regular liver function tests during treatment.

In terms of precautions, patients should strictly follow the doctor's instructions when using clofazimine and should not increase or decrease the dose on their own or stop the drug suddenly to avoid affecting the efficacy or causing rebound reactions. For pregnant and lactating women, the risks and benefits of drug use need to be carefully evaluated and the decision whether to use it should be made under the guidance of a doctor. During medication, avoid using it with alcohol or other drugs that may increase the burden on the liver to reduce the incidence of adverse reactions. Since clofazimine is a long-term treatment drug, patients should maintain regular follow-up visits and promptly report any abnormal symptoms.

Reference materials:https://www.novartis.com/our-products/pipeline/clofazimine